Financhill
Sell
41

VWAGY Quote, Financials, Valuation and Earnings

Last price:
$10.34
Seasonality move :
3.94%
Day range:
$10.34 - $10.55
52-week range:
$8.57 - $16.48
Dividend yield:
9.44%
P/E ratio:
3.91x
P/S ratio:
0.15x
P/B ratio:
0.26x
Volume:
200.3K
Avg. volume:
305.2K
1-year change:
-26.64%
Market cap:
$51.8B
Revenue:
$348.9B
EPS (TTM):
$2.64
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $282.8B $254.5B $296B $294.3B $348.9B
Revenue Growth (YoY) 1.56% -10% 16.3% -0.59% 18.56%
 
Cost of Revenues $227.8B $210.1B $240.1B $239.3B $282.8B
Gross Profit $55B $44.5B $55.9B $55B $66.1B
Gross Profit Margin 19.45% 17.48% 18.88% 18.7% 18.93%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $34.4B $31.8B $35.1B $33.2B $36.9B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $37.1B $33B $37B $35.8B $38.3B
Operating Income $17.9B $11.5B $18.9B $19.2B $27.8B
 
Net Interest Expenses $2.3B $2.3B $1.5B $1.4B $2B
EBT. Incl. Unusual Items $20.5B $13.3B $23.8B $23.3B $25.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.8B $3.2B $5.6B $6.6B $5.7B
Net Income to Company $20.5B $13.3B $23.8B $23.3B $25.1B
 
Minority Interest in Earnings -$160.1M $49.1M -$54.4M -$416.6M -$1.4B
Net Income to Common Excl Extra Items $15.5B $10.1B $18.2B $16.3B $18B
 
Basic EPS (Cont. Ops) $2.98 $1.90 $3.50 $3.13 $3.46
Diluted EPS (Cont. Ops) $2.98 $1.90 $3.50 $3.13 $3.46
Weighted Average Basic Share $5B $5B $5B $5B $5B
Weighted Average Diluted Share $5B $5B $5B $5B $5B
 
EBITDA $50.4B $46.3B $58.5B $55B $58.8B
EBIT $23.4B $15.9B $26.1B $25B $29B
 
Revenue (Reported) $282.8B $254.5B $296B $294.3B $348.9B
Operating Income (Reported) $17.9B $11.5B $18.9B $19.2B $27.8B
Operating Income (Adjusted) $23.4B $15.9B $26.1B $25B $29B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $69.4B $67.1B $71.2B $85.8B $86.3B
Revenue Growth (YoY) 1.63% -3.29% 6.06% 20.58% 0.54%
 
Cost of Revenues $57.2B $56.6B $58.4B $71.2B $71.9B
Gross Profit $12.2B $10.5B $12.8B $14.6B $14.4B
Gross Profit Margin 17.57% 15.67% 17.92% 17.01% 16.64%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8B $8.6B $8B $9.2B $9.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $8.5B $7.5B $8.5B $9.3B $11.2B
Operating Income $3.7B $3.1B $4.3B $5.3B $3.1B
 
Net Interest Expenses $505.2M $489.3M $2.1B $26.1M $1B
EBT. Incl. Unusual Items $4.2B $3.6B $3B $6.3B $2.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1B $207.5M $808.9M $1.6B $857.9M
Net Income to Company $4.1B $3.3B $2.1B $6.3B $2.8B
 
Minority Interest in Earnings -$24.6M -$8.3M -$25.2M -$341.9M -$231M
Net Income to Common Excl Extra Items $3.2B $3.4B $2.1B $4.4B $1.5B
 
Basic EPS (Cont. Ops) $0.60 $0.65 $0.39 $0.84 $0.27
Diluted EPS (Cont. Ops) $0.60 $0.65 $0.39 $0.84 $0.27
Weighted Average Basic Share $5B $5B $5B $5B $5B
Weighted Average Diluted Share $5B $5B $5B $5B $5B
 
EBITDA $11.5B $11.2B $13.7B $13.4B $12.1B
EBIT $3.7B $3.1B $4.3B $5.3B $3.1B
 
Revenue (Reported) $69.4B $67.1B $71.2B $85.8B $86.3B
Operating Income (Reported) $3.7B $3.1B $4.3B $5.3B $3.1B
Operating Income (Adjusted) $3.7B $3.1B $4.3B $5.3B $3.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $248.5B $303.8B $288.3B $332.9B $351.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $207.9B $244.7B $231.3B $271.4B $287.9B
Gross Profit $40.6B $59.1B $57B $61.4B $64B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $32.4B $34.7B $33.6B $35.9B $37.7B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $35.7B $32.4B $36.3B $42.7B $39.9B
Operating Income $4.8B $26.7B $20.7B $18.8B $24.2B
 
Net Interest Expenses $2.2B $2.5B $1.6B -- $2.5B
EBT. Incl. Unusual Items $6.8B $28.3B $25.2B $24.4B $19.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6B $6.2B $6.6B $7.3B $4.4B
Net Income to Company $6.9B $27.5B $24.1B $25.4B $19.6B
 
Minority Interest in Earnings -$26M -$98.7M -$46.5M -$1.5B -$1.2B
Net Income to Common Excl Extra Items $5.3B $22B $18.5B $15.6B $13.9B
 
Basic EPS (Cont. Ops) $0.93 $4.25 $3.57 $2.98 $2.64
Diluted EPS (Cont. Ops) $0.93 $4.25 $3.57 $2.98 $2.64
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $38.9B $63.8B $60.5B $52.5B $57.1B
EBIT $10.2B $31.3B $27.7B $24.4B $25.4B
 
Revenue (Reported) $248.5B $303.8B $288.3B $332.9B $351.9B
Operating Income (Reported) $4.8B $26.7B $20.7B $18.8B $24.2B
Operating Income (Adjusted) $10.2B $31.3B $27.7B $24.4B $25.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $175.4B $223.4B $215.6B $255B $258B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $149B $182.9B $174B $206.9B $211.9B
Gross Profit $26.4B $40.5B $41.6B $48.1B $46.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $22.6B $25.5B $24B $26.8B $27.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $24.3B $23.7B $23.2B $30.5B $32.1B
Operating Income $2.1B $16.8B $18.4B $17.6B $14B
 
Net Interest Expenses $1.6B $1.8B $2.1B $573.5M $1.3B
EBT. Incl. Unusual Items $2.7B $17.1B $18.4B $19.2B $13.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $634.6M $3.5B $4.6B $5.2B $3.9B
Net Income to Company $2.6B $16.8B $17.1B $19.3B $13.8B
 
Minority Interest in Earnings $38.2M -$105.9M -$94.6M -$1.2B -$924.9M
Net Income to Common Excl Extra Items $2.1B $13.5B $13.8B $12.8B $8.7B
 
Basic EPS (Cont. Ops) $0.33 $2.60 $2.66 $2.45 $1.64
Diluted EPS (Cont. Ops) $0.33 $2.60 $2.66 $2.45 $1.64
Weighted Average Basic Share $15B $15B $15B $15B $15B
Weighted Average Diluted Share $15B $15B $15B $15B $15B
 
EBITDA $24.3B $41B $43.1B $40.4B $38.7B
EBIT $2.1B $16.8B $18.4B $17.6B $14B
 
Revenue (Reported) $175.4B $223.4B $215.6B $255B $258B
Operating Income (Reported) $2.1B $16.8B $18.4B $17.6B $14B
Operating Income (Adjusted) $2.1B $16.8B $18.4B $17.6B $14B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $29B $41.7B $45B $31.3B $48B
Short Term Investments $22.5B $31.2B $30.7B $44.6B $34.8B
Accounts Receivable, Net $64.9B $68.6B $59.7B $64.6B $74.3B
Inventory $52.1B $53.5B $49.1B $54.8B $57.4B
Prepaid Expenses $248.7M $354.2M $389.5M $1.2B $1.8B
Other Current Assets $1.1M -$2.5M -- -$1.1M -$1.1M
Total Current Assets $210B $239.8B $226.8B $240.4B $264.9B
 
Property Plant And Equipment $128.9B $140.9B $139.7B $132.2B $144.8B
Long-Term Investments -- -- -- -- --
Goodwill $26B $28.7B $29.6B $28.1B $29.1B
Other Intangibles $48.1B $54.9B $58.3B $61.2B $69.4B
Other Long-Term Assets -- $1.2M -$2.3M -$1.1M -$2.2M
Total Assets $546.7B $611.4B $598.5B $604.8B $663.6B
 
Accounts Payable $25.5B $27.9B $26.7B $30.8B $34.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.1B $1.2B $1.3B $1.2B $1.2B
Other Current Liabilities $2.9B $2.6B $2.5B $2.4B $2.5B
Total Current Liabilities $188.1B $203.4B $186.1B $196B $227.6B
 
Long-Term Debt $118.7B $131.9B $140.3B $122.1B $125.7B
Capital Leases -- -- -- -- --
Total Liabilities $408.2B $453B $433B $413.6B $453.7B
 
Common Stock $1.4B $1.6B $1.5B $1.4B $1.4B
Other Common Equity Adj -- -- -- -- --
Common Equity $136.4B $156.3B $163.5B $177.3B $194.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.1B $2.1B $1.9B $13.9B $15.7B
Total Equity $138.5B $158.4B $165.5B $191.2B $209.9B
 
Total Liabilities and Equity $546.7B $611.4B $598.5B $604.8B $663.6B
Cash and Short Terms $51.5B $72.9B $75.7B $75.9B $82.8B
Total Debt $182.2B $206.9B $200.5B $184.5B $207.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $53.5B $42.5B $32.3B $48.3B $57.4B
Short Term Investments $24.3B $25.6B $23.1B $27.4B $30.8B
Accounts Receivable, Net $87B $81.4B $76.6B $91.5B $99B
Inventory $50.8B $50.5B $50.4B $60.3B $64.8B
Prepaid Expenses $281.8M $264.5M $467.9M $1.7B $2.2B
Other Current Assets -- -$2.3M -- -$1.1M --
Total Current Assets $242.1B $227B $228.4B $259.4B $288.4B
 
Property Plant And Equipment $131.6B $140.3B $121.8B $135.3B $153.5B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.2M -- -$982.9K -- -$1.1M
Total Assets $588.5B $599.4B $564.2B $629.4B $705.2B
 
Accounts Payable $27.9B $25.8B $28.8B $31.8B $36.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.1B $1.2B $1.1B $1.1B $1.3B
Other Current Liabilities $68.1B $70.3B $68.3B $71B $78.5B
Total Current Liabilities $213.9B $192.7B $172.4B $213.1B $250.7B
 
Long-Term Debt $119.4B $132.7B $116.9B $123.4B $137.5B
Capital Leases -- -- -- -- --
Total Liabilities $444.8B $435.1B $378.4B $429.2B $491.2B
 
Common Stock $1.5B $1.5B $1.3B $1.4B $1.4B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9B $2B $12.3B $15.1B $16.2B
Total Equity $143.7B $164.3B $185.8B $200.2B $214B
 
Total Liabilities and Equity $588.5B $599.4B $564.2B $629.4B $705.2B
Cash and Short Terms $77.7B $68.1B $55.4B $75.7B $88.2B
Total Debt $200.8B $197.7B $166.4B $196.8B $212.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $20.5B $13.3B $23.8B $23.3B $25.1B
Depreciation & Amoritzation $27B $30.4B $32.3B $30B $29.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$13.1B $1.1B $7.4B -$9.9B -$19.2B
Change in Inventories -$754.5M $1.5B $2.5B -$8.8B -$2.2B
Cash From Operations $20.1B $28.4B $45.7B $30.1B $21B
 
Capital Expenditures $21.7B $20.3B $21.9B $23.9B $27.9B
Cash Acquisitions -$1B -$1.2B -$7.3B -$3.4B -$3B
Cash From Investing -$23.7B -$25.9B -$30.9B -$44.1B -$21.4B
 
Dividends Paid (Ex Special Dividend) -$3.2B -$3.4B -$3.6B -$4.6B -$12.7B
Special Dividend Paid
Long-Term Debt Issued $29B $28.8B $38.6B $25.2B $40.9B
Long-Term Debt Repaid -$22.1B -$22.6B -$36.2B -$27B -$35.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$3.5B $3.8B -$5.3B $12.5B $24.6B
Cash From Financing -$968.4M $8.7B -$9.2B $4.5B $17.3B
 
Beginning Cash (CF) $31.5B $27.8B $39.6B $41.3B $32.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$4.5B $11.2B $5.6B -$9.6B $16.8B
Ending Cash (CF) $27.2B $38.2B $46.3B $31.4B $47.1B
 
Levered Free Cash Flow -$1.6B $8.2B $23.8B $6.1B -$7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $10.7B $7B $6.2B $5.8B --
Depreciation & Amoritzation $7.3B $8.4B $6.6B $6.9B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.5B $1.5B -$6.2B -$5.5B --
Change in Inventories -$312.5M $515.7M -$2.2B $4.7B --
Cash From Operations $7B $11.6B $3B $7.3B --
 
Capital Expenditures $7.4B $8.4B $9.4B $9.7B --
Cash Acquisitions $13.2M -$7.3B -$623.5M -$2.1B --
Cash From Investing -$8.7B -$10.9B -$25B -$13B --
 
Dividends Paid (Ex Special Dividend) -$2.8B -$41.9M -$271.5M $12.6M --
Special Dividend Paid -- -- $2M -- --
Long-Term Debt Issued $7B $9.2B $9.7B $13.9B --
Long-Term Debt Repaid -$7.9B -$8.1B -$6.1B -$14.7B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$8B $2B $18.1B $5.7B --
Cash From Financing -$12.1B $2.6B $19.4B $4.6B --
 
Beginning Cash (CF) $52.7B $42.4B $33.3B $49.8B --
Foreign Exchange Rate Adjustment -$81.3M $422.4M -$1.1B -$1.3B --
Additions / Reductions -$13.8B $3.3B -$2.7B -$1.2B --
Ending Cash (CF) $38.2B $46.3B $31.4B $47.1B --
 
Levered Free Cash Flow -$325.7M $3.2B -$6.4B -$2.4B --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $6.9B $27.5B $24.1B $25.4B $19.6B
Depreciation & Amoritzation $29.8B $31.2B $31.9B $29.5B $31.9B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $160M $4.4B -$2.2B -$19.8B -$15.6B
Change in Inventories $5.2B $1.7B -$6.1B -$9.1B -$2.7B
Cash From Operations $27.3B $41.1B $38.7B $16.6B $20.3B
 
Capital Expenditures $21.3B $20.8B $22.9B $27.7B $28.7B
Cash Acquisitions -$1.5B $13.2M -$10B -$1.5B -$3.1B
Cash From Investing -$28B -$28.7B -$30B -$33.4B -$34.4B
 
Dividends Paid (Ex Special Dividend) -$573M -$6.3B -$4.4B -$13B -$6.3B
Special Dividend Paid
Long-Term Debt Issued -- $36.5B $24.7B $36.6B $45.2B
Long-Term Debt Repaid -- -$36B -$29B -$26.7B -$40.2B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $7.5B -$15.4B -$3.6B $37B $25.8B
Cash From Financing $19.1B -$23.9B -$12.4B $32.2B $21.9B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $18.4B -$11.5B -$3.6B $15.4B $7.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.1B $20.3B $15.8B -$11B -$8.5B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $13.3B $23.8B $23.3B $25.1B $13.8B
Depreciation & Amoritzation $30.4B $32.3B $30B $29.8B $25B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $1.1B $7.4B -$9.9B -$19.2B -$10B
Change in Inventories $1.5B $2.5B -$8.8B -$2.2B -$7.4B
Cash From Operations $28.4B $45.7B $30.1B $21B $13B
 
Capital Expenditures $20.3B $21.9B $23.9B $27.9B $19.1B
Cash Acquisitions -$1.2B -$7.3B -$3.4B -$3B -$1B
Cash From Investing -$25.9B -$30.9B -$44.1B -$21.4B -$21.4B
 
Dividends Paid (Ex Special Dividend) -$3.4B -$3.6B -$4.6B -$12.7B -$6.3B
Special Dividend Paid -- -- $2M -- --
Long-Term Debt Issued $28.8B $38.6B $25.2B $40.9B $31.3B
Long-Term Debt Repaid -$22.6B -$36.2B -$27B -$35.3B -$25.5B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $3.8B -$5.3B $12.5B $24.6B $20.1B
Cash From Financing $8.7B -$9.2B $4.5B $17.3B $17.4B
 
Beginning Cash (CF) $156.6B $175.2B $162.2B $161.9B $157.1B
Foreign Exchange Rate Adjustment -$850.8M $1.1B -$300.6M -$1.9B -$334.3M
Additions / Reductions $11.2B $5.6B -$9.6B $16.8B $9B
Ending Cash (CF) $167.9B $181.2B $149.6B $177B $166.4B
 
Levered Free Cash Flow $8.2B $23.8B $6.1B -$7B -$6.1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Intuitive Surgical Stock Surging?
Why Is Intuitive Surgical Stock Surging?

Surgeries are scary for lots of reasons, not least because…

Why Did Stanley Druckenmiller Buy ARS Pharmaceuticals?
Why Did Stanley Druckenmiller Buy ARS Pharmaceuticals?

Billionaire Stanley Druckenmiller has been making large changes to his…

Is CVS Health Stock Undervalued?
Is CVS Health Stock Undervalued?

CVS Health (NYSE:CVS) share price declined by over 23% over…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 39x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Sell
38
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 101x

Alerts

Buy
54
DECK alert for Feb 1

Deckers Outdoor [DECK] is down 20.35% over the past day.

Sell
49
EXOD alert for Feb 1

Exodus Movement [EXOD] is down 18.88% over the past day.

Buy
69
HZO alert for Feb 1

MarineMax [HZO] is down 0.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock